Stock & Company Details
Enlivex Therapeutics Ltd $ENLV
Price:
N/A
N/A
N/A
$4M
52 Week High:
N/A
10 Day Average Volume:
N/A
0.02
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENLV technical indicators
Latest Enlivex Therapeutics Ltd (ENLV) indicator readings as of 2026-10-29.
ENLV's 14-day RSI is 83.6, in overbought territory. At $2.54 it is trading 101.9% above its 200-day moving average of $1.26, and above its 50-day average of $0.84. Price sits above the upper Bollinger Band ($-1.09 to $2.30). ADX reads 56.1, indicating a trending market.
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Finance Bot
Ask your questions
Start by typing a question below.
